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The induction of adaptive immunological memory, mediated by T and B cells, plays
an important role in protective immunity to pathogens induced by previous infections
or vaccination. Naive CD4+ T cells that have been primed by antigen develop into
memory or effector cells, which may be distinguished by their capability to exert
a long-term and rapid response upon re-challenge by antigen, to produce distinct
cytokines and surface marker expression phenotypes such as CD45RA/RO, CD27,
CD62L, and CCR7. Moreover, a distinct lineage of memory T cells populates tissues
(tissue-resident memory T cells or TRM cells) which orchestratea the response to
pathogens re encountered at tissue sites. Recent evidence, however, has highlighted
that CD4+ naive T cells are much more heterogeneous that previously thought, and
that they harbor diversity in phenotypes, differentiation stages, persistence, functions,
and anatomic localizations. These cells represent cellular subsets that are extremely
heterogeneous and multifunctional at their very initial stages of differentiation, with the
potential to become “atypical” memory and effector cells. In this mini review, we focus
on recently obtained data from studies in humans, in which this newly recognized
heterogeneity in the naive T cell pool was discovered in terms of surface marker
expression, cytokine production, or transcriptomic profiles. The deep analysis of immune
functions at the single cell level combined with a better understanding of the generation
and maintenance of the various atypical memory CD4+ T cell subsets with a naive-like
phenotype will be important in immune-monitoring of vaccination and immunotherapies
in infectious diseases.
Keywords: CD4+ T cells, naive T cells, effector T cells, immunological memory, cytokines, infection, M.
tuberculosis infection
INTRODUCTION
CD4+ T lymphocytes mature in the thymus after passing through the processes of positive and
negative selection and migrate to secondary lymphoid organs. These mature T lymphocytes, that
have not yet encountered antigen (naive T cells), continuously recirculate between secondary
lymphoid organs and blood. Upon recognition of specific antigen/MHC complexes naive CD4+
T cells proliferate and differentiate toward effector T cells, which provide immediate protection.
Most of these effector T cells subsequently die by apoptosis, but a subset of antigen-specific T cells
Caccamo et al. Atypical Human Memory CD4T Cells
will persist in an individual as memory T cells (1). There are
two types of memory T cells in the circulation, central (TCM)
and effector (TEM) memory T cells: the former show self-renewal
potential, home to secondary lymphoid organs but lack effector
functions, while the latter possess immediate effector functions
and can rapidly migrate to peripheral tissues to provide antigen
elimination (2). Moreover, a distinct lineage of tissue-resident
memory T cells (TRM cells) has been described in the last
years, which are confined to different tissues and orchestrate the
response to pathogens re encountered at tissue sites.
Due to thymic regression with age, the survival of the naive
T cell pool is maintained by homeostatic mechanisms in the
periphery, including IL-7 and low affinity T-cell receptor (TCR)-
recognized self peptide/MHC complexes, which however do not
induce differentiation into central or effector memory T cells (2).
Since naive CD4+ T cells in humans have a lifespan of 6–10 years
(3), this homeostatic mechanism maintains a broad repertoire
of T cell subsets and TCR specificities in the periphery over
prolonged periods of time.
The naive CD4+ T cell compartment has long been
considered as consisting of a homogeneous population of
antigen-inexperienced cells (2), identified by specific surface
markers. In humans, naive CD4+ T cells typically express CCR7,
CD62L, and CD45RA, while lacking expression of CD45RO (2).
CCR7 and CD62L are involved in the homing of T cells to
secondary lymphoid organs (SLOs) and interact with ligands
expressed on high endothelial venules (HEV). CD45RA and
CD45RO play a role in TCR signal transduction, and their
expression characterize the different T cells subsets (4). However,
there is increasing evidence that this phenotypic identification of
naive T cells includes populations equipped with memory and/or
effector functions, thus making it clear that the “naïve” CD4+ T
cell compartment spans a whole spectrum of cells with different
properties (Figure 1).
Here we will review specifically the recent evidence for the
existence of distinct subsets of CD4+ effector/memory T cells
with a naive phenotype, as they may play an important role in
different clinical settings, and need to be considered in immune-
monitoring strategies in vaccination and immunotherapy.
Similar subsets of CD8+ effector/memory T cells with a naive
phenotype have also been described, but will not be discussed
further here as they have been described elsewhere (4).
EFFECTOR/MEMORY CD4+ T CELLS WITH
A NAIVE PHENOTYPE
Naive Receptor+ CD4+ T Cells (TNR
+)
Within the human naive CD4+ subset, classically identified as
CD45RO−, CD62L+, CD27+, and CD11adim, Song et al. (5)
have identified in the blood and tonsils of healthy individuals,
a population of cells expressing CCR4 and/or CXCR3, which
accounted for ∼20% of all cells in the naive compartment.
They designated this CD4+ population as an alternative naive
phenotype, T+NR (T naive receptor
+) cells. The T+NR cells have
T cell receptor (TCR) rearrangement excision circles (TREC)
numbers intermediate between naive and memory CD4+ T cells,
while having lost CD31 expression, a marker that usually has
been proposed as identifier of naive cells that have undergone
homeostatic division. In fact, the number of TRECs diminishes
in each cell division (since TRECs are not copied during cell
division) and CD31 is expressed on naive CD4+ T cells that
have recently egressed from the thymus where its expression
is downregulated following TCR stimulation. Moreover, T+NR
cells use a broad TCR Vβ repertoire but with some proof
of clonal expansion, suggesting antigen specificity, and upon
polyclonal stimulation with PMA and ionomycin they produced
low, yet significant levels of either IL-4 or IFN-γ, characteristic
of differentiated cells. However, it is not known whether T+NR
cells produce single or multiple cytokines, including TNF-
α. Therefore, although the CD4+ T+NR cells express a naive
surface phenotype, they display typical features of a memory cell
population.
Stem Cell Memory CD4+ T Cells (TSCM)
Within the CD4+ (and CD8+) T cell compartment of CD45RA+,
CCR7+ phenotypically naive cells, a proportion of T cells
is clearly distinct from classically naive T cells as they
display phenotypical and functional characteristics reminiscent
of effector and memory T cells. Among these naive-like memory
T cells, a subset termed stem cell memory T (TSCM) cells
has been identified based on the expression of CD95, CD122,
CXCR3, and the integrin CD11a (6, 7). CD95 is a surface marker
molecule belonging to members of the TNF family and functions
as a death receptor because its signaling induces apoptosis
through activation of caspase-8 (8). Recent data, however, have
highlighted that CD95 may play a role as a costimulatory surface
molecule of CD4+ and CD8+ T cells (9, 10). This molecule
is upregulated in activated T cells and stably expressed in all
memory cells (11). CD122 is the β-chain of the IL-2 and IL-15
receptors. It is progressively upregulated along the differentiation
of memory T cells, displaying different functions in terms of
expansion, survival, and homeostatic features of memory T cell
subsets (12, 13). The chemokine receptor CXCR3 (6) regulates
lymphocyte trafficking, possibly allowing their migration into
inflammatory sites guided by CXCR3 ligands, CXCL9 (MIG),
CXCL10 (IP-10), and CXCL11 (I-TAC) (14). Finally, CD11a (the
α subunit of LFA1) is involved in homing to SLOs and inflamed
sites and in the adhesion to antigen-presenting cells (6).
These so-called TSCM cells are generated during primary
immune responses and are considered a reservoir for thememory
pool, in line with their unique ability for self-renewal through still
unidentified mechanisms (6). TSCM cells express a substantially
lower TREC content than the naive T cell population as a whole,
similar to non-naive T cells, and can rapidly acquire effector
functions (cytokine production) upon antigenic and homeostatic
stimulation. Despite low TREC levels, high expression levels
of the intracellular proliferation marker Ki-67 and a restricted
TCR repertoire (15) (characteristics suggesting that they have
undergone several rounds of division), TSCM cells preserve their
naive-like phenotype. It has been suggested that CD8+ TSCM
cells induced by a yellow fever vaccine in humans can stably
persist for more than 25 years and are maintained by extensive
proliferation (16).
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FIGURE 1 | Hypothetical model of human CD4+ T cell differentiation. Naive T cells (TN) upon specific antigen stimulation progressively differentiate into different
population of effector/memory cells, including T cells with a naive-like phenotype but exerting several different effector functions, such as cytokine production (TNR,
TCNP, and TSCM cells). TNR, naive receptor memory T cells, TSCM, stem memory T cells; TCM, central memory T cells; TEM, effector memory T cells.
Interestingly, Mpande et al. (17) have also reported the
identification of seemingly naive CD4+ T cells that are induced
by primaryM. tuberculosis infection. These cells are distinct from
naive T cells, display a TSCM phenotype and produce IL-2, TNF-
α, and IFN-γ. This has been identified by transcriptomic analysis,
showing that bulk CD4+ TSCM and M. tuberculosis -specific
TSCM cells expressed chemokine receptor and cytotoxic molecule
transcripts, which were mostly undetectable in bulk T naive cells.
Moreover, the comparison of the different subsets of CD4+ T
cells showed that M. tuberculosis-specific TSCM cells possessed
the least differentiated M. tuberculosis-specific phenotypic and
functional profile, suggesting that M. tuberculosis-specific TCM
cells appear as an intermediate subset before TSCM cells further
differentiate intoM. tuberculosis-specific effector CD4+ T cells.
Cytokine-Producing Naive CD4+ T Cells
(TCNP)
Very recently, we have identified in the peripheral blood of
patients with tuberculosis a novel human effector/memory CD4+
T cell subset with a non-classical, naive-like T cell phenotype.
These cells were CD45RO−, CD45RA+, CCR7+, CD62L+,
CD27+, and capable of rapidly secreting multiple cytokines
(IFN-γ, TNF-α, IL-2) in response to different M. tuberculosis
antigens (18). We have designated this CD4+T cell population
as TCNP cells (T cells that are able to produce cytokines with
a naive phenotype). TCNP cells were further phenotyped as
CD95lo CD28int CD49dhi CXCR3hi and a sizeable fraction
(ranging from 50 to 80%) also expressed CD31. Following
curative tuberculosis treatment, the size of this T cell subset
significantly decreased, suggesting that these cells are markers of
active tuberculosis disease during infection with M. tuberculosis
and probably expand in response to actively multiplying bacilli.
Accordingly, subjects with latent M. tuberculosis infection had
a lower proportion of responding CD4+ TCNP cells in the
peripheral blood, than tuberculosis patients.
Compared to TSCM cells, TCNP cells express higher levels
of CD49d and comparable levels of CXCR3, but they do not
express CD95 (19, 20). The α4 integrin CD49d associates with β-
integrin subunits to form α4β7 or α4β1 heterodimers that regulate
the trafficking of effector memory T cells to inflamed tissues.
Similarly, CXCR3 regulates lymphocyte trafficking in response to
its ligands as above reported. Therefore, it is likely that CD4+
TCNP cells may be able to rapidly traffic to sites ofM. tuberculosis
infection and engage in the control of bacterial replication by
virtue of their ability to secrete the type-1 cytokines, IFN-γ,
and TNF-α, which are well known players in anti-mycobacterial
protective immune responses (21).
Our findings are reminiscent of the CD8+ T cells reported
by Pulko et al. (22), that produced IFN-γ but expressed a naive
phenotype, and were termed TMNP cells (memory T cells with
a naive phenotype). Interestingly, and similar to our findings in
tuberculosis, these CD8+ TMNP cells were increased in patients
with active West Nile virus infection, and their frequency and
numbers correlated with the severity of infection.
Thus, our findings demonstrate that CD4+ TCNP cells
are polyfunctional T cells that differ both phenotypically
and functionally from the quiescent CD4+ T naive
population.
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But how are these CD4+ TCNP cells (and related subsets)
generated ? Sallusto (2) originally proposed a “linear progression”
model of differentiation, suggesting that naive T lymphocytes
primed by specific antigen hierarchically differentiate into
TCM cells which, in turn, further differentiate into TEM cells.
Thus, refining and extending this progressive model of T cell
differentiation, we now hypothesize that the transition fromnaive
T cells to TCM cells includes the intermediate steps of TNR, TCNP,
TSCM and, possibly, TMNP and other naive-like T cells (Figure 1).
This possibility has been demonstrated for TSCM cells and for
memory CD8+ TMNP cells (6, 22), but needs to be confirmed for
all other atypical effector/memory CD4+ T cells with a naive-like
phenotype.
Our data show that atypical, polarized subsets of naive-like
CD4+ T cells armed with effector functions can be generated
at many points along the differentiation/activation pathway,
giving rise to quite heterogeneous effector populations that
do not fulfill classical subset phenotypes (23, 24). Besides,
we have found that CD4+ TCNP cells are not oligoclonal,
but show highly heterogeneous Vβ gene segment usage (18).
Vβ5.1, Vβ7.1, Vβ8, Vβ12, Vβ13.2, Vβ16, and Vβ17 gene
element families were equally expressed among CD4+ TCNP
and CD4+ TEM cells, indicating that the CD4
+ TCNP cell
population might arise in response to similar or even the same
M. tuberculosis antigens that drove the generation of highly
differentiated CD4+ TEM cells. Thus, the TCR Vβ data are in
agreement with the observation that CD4+ TCNP cells compose
diverse and likely stable effector/memory populations that have
accumulated over time driven, at least in part, by antigen.
In fact, if the CD4+ TCNP pool would have been derived
principally from recently activated cells that were expressing
this surface phenotype only transiently, we would have expected
some TCR Vβ families overexpressed in the CD4+ TCNP
population.
However, this does not exclude the possibility that TCNP cells
arise by homeostatic proliferation of naive T cells. It has been
suggested that CD4+ TNR+ cells do not seem to have arisen by
homeostatic proliferation, based on the lack of CD31 expression
(5). Conversely, IL-7 and IL-15 have been successfully used to
generate TSCM cells (including cytomegalovirus-specific TSCM
cells) from naive T cell precursors (19, 25): IL-7 is essential for
the development of these cells, whereas IL-15 primarily sustains
their expansion (19, 25).
Whether or not the CD4+ TCNP cells we have described
represent a stable or transient T cell subset (5, 6, 23, 26), if
they derive from antigen-driven or cytokine-driven homeostatic
proliferation and how this population is related to TSCM (6,
23), TMNP (18), or other populations of effector/memory cells,
remain to be determined in future research including studies in
experimental animal models.
CONCLUSIONS
Our data support the concept that, despite their seemingly
naive cell surface phenotype, the CD4+ TCNP cell population
contains effector/memory cells, and therefore, the surface
markers commonly used to distinguish and purify naive and
effector/memory human CD4+ T cells, particularly in adults,
are inadequate to the latter purpose. The different naive-like
effector/memory CD4+ T cells reviewed here appear to have
important and specific roles in protective immune responses in
infectious diseases including tuberculosis.
The question remains whether atypical naive-like
effector/memory CD4T cells should remain incorporated
in the naive T cell compartment, since their classical membrane
phenotype appears “naïve,” or due to the evidence that these
cells are antigen-experienced, they should be considered as
an early stage of the effector T cell pool compartment. Our
data support the latter view. Further work will be needed
to understand whether and how atypical CD4+naive-like
effector/memory cells can be induced by vaccination, and
whether they are associated with long-term memory responses
and protection (27). The existence of naive-like T cell with
effector functions may also have much wider implications for
research in aging, neonatal immunity, and immune-monitoring
of the response to vaccination. In both elderly individuals
and neonates, immune responses to infections (including
tuberculosis) and vaccination are diminished, constituting a
major cause of morbidity and mortality. In elderly individuals,
a major cause for this impairment is the progressive decline
in thymus output with a consequent reduction of the naive T
cell pool and expansion of oligoclonal populations of memory
cells (28). Alternatively, one could speculate that the altered
functional responsiveness of naive T cells in elderly individuals
may be the result of a shift from truly naive to more mature
naive-like T cells. While our study on TCNP cells (18) did not
include old individuals (in fact the oldest patient enrolled in
our study was 42-years old), results on other naive-like T cell
populations have been inconsistent. Pulko et al. (22) found
that both CD8+ and CD4+ TMNP cell percentages increased in
people over 65 years but this increase was relative. In fact, the
absolute number of these cells also diminished with age, albeit
less rapidly than that of truly naive T cells. In another study, the
frequency of circulating TSCM cells did not vary substantially with
age (29).
Conversely, the neonatal immune system is largely dominated
by truly naive T cells, with very poor representation of
memory cells and a relatively high proportion of recent
thymic emigrants (RTE) (30). The very poor (if any) memory
response in neonates is believed to be compensated in part
by the innate-like behavior of RTE due to their capacity
to produce IL-8. However, it is necessary to investigate the
role that naive-like T cells could play in host defense in
early life, with particular attention to understanding and
filling the gap in the transition from innate to adaptive
responses.
The big question that remains and has not been touched
upon is: why would these cells persist in the naive compartment
if they have seen antigen, are there any advantages to the
cells to remain CD45RA+ but CD45RO−? Are they only
weakly activated? Are they functionally equally powerful as
compared to fully differentiated memory T cells? Do they
have any unique functional properties? Any thoughts why we
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would have such atypical cells in such high numbers? A better
understanding of the mechanisms involved in the generation
and differentiation of the atypical naive-like CD4+ T cells may
provide novel tools for immunization in early life and in elderly
individuals, and more generally for improving vaccination and
immunotherapeutic strategies in human infectious disease and
cancer.
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